<DOC>
	<DOCNO>NCT00487461</DOCNO>
	<brief_summary>The purpose study test whether treatment drug call Simvastatin prevents improve outcome patient Subarachnoid bleeding . Simvastatin currently approve treatment high cholesterol level .</brief_summary>
	<brief_title>Use Simvastatin Prevention Vasospasm Aneurysmal Subarachnoid Hemorrhage</brief_title>
	<detailed_description>Aneurysmal Subarachnoid hemorrhage SAH ( bleed surface brain ) affect 10 per 100,000 population year . For survivor initial hemorrhage , delay narrow blood vessel ( vasospasm ) relate delayed stroke common serious complication . Narrowing blood vessel affect 30 % patient bleed . Despite maximum therapy , nearly 50 % patient symptomatic vasospasm develop stroke . Because cerebral vasospasm remain leading cause morbidity mortality aSAH , critically important issue need study . One hundred fifty patient randomize , 50 arm study . Patients enrol study receive drug ( either Simvastatin 40 mg Simvastatin 80 mg per mouth daily ) , control group receive sugar tablet . The treatment continue total 21 day . The neurological ability ( Stroke Outcome measure , include application review ) day 21 post aSAH review time discharge well 6 month follow .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Vasospasm , Intracranial</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>1885 year old inclusive Subarachnoid hemorrhage diagnose CT admission Randomizable within 732 hour subarachnoid hemorrhage Saccular intracranial aneurysm proven cerebral angiography compute tomographic angiography ( CTA ) Surgical endovascular obliteration Able obtain write informed consent patient surrogate Pregnancy , confirm routine urine test admission Elevated liver function test time randomization , define three time upper limit normal On Statins , niacin , fibrate therapy within 30 day presentation Any vasospasm initial diagnostic angiogram Glasgow Coma Scale 5 less time randomization History liver disease active liver disease Hypersensitivity statins Patient take medication recommend concomitant use Simvastatin ( 40 80 mg ) per product label</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>SAH</keyword>
	<keyword>Vasospasm</keyword>
</DOC>